our study explores the effectiveness of two advanced sperm selection techniques-PICSI and the ZyMot microfluidic device-in improving outcomes of Intracytoplasmic Sperm Injection (ICSI). It aims to compare their impact on fertilization rates, embryo quality, and clinical pregnancy success, helping determine which method offers superior results in assisted reproductive technology.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
300
theses techniques to selection mature and lowest DNA fragmentation sperm for injection in oocyte
Primary outcome measure
1• clinical pregnancy rate:- defined as the presence of a fetal heartbeat or gestational sac. • Unit of Measure: Percentage (%)
Time frame: 6-9 weeks after embryo transfer.
secondary outcome measure
1- Miscarriage rate: Defined as pregnancy loss following confirmation of clinical pregnancy. Unit of Measure: Percentage (%)
Time frame: 1-After 6 weeks of gestation.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.